Garfield, NJ, United States of America

Michael J Konkel


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Garfield, NJ (US) (2004 - 2008)
  • Fair Lawn, NJ (US) (2006 - 2012)

Company Filing History:


Years Active: 2004-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael J Konkel: Innovator in Pharmaceutical Composition

Introduction

Michael J Konkel is a notable inventor based in Garfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental health conditions. With a total of 6 patents, his work focuses on innovative methods and compounds that aim to improve therapeutic outcomes.

Latest Patents

One of Konkel's latest patents involves the use of GALR3 receptor antagonists for the treatment of depression and/or anxiety. This invention is directed towards indolone derivatives that act as antagonists for the GALR3 receptor. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of the compound and a pharmaceutically acceptable carrier. Additionally, it describes a process for creating this pharmaceutical composition, ensuring that the methods are both effective and practical for therapeutic use.

Career Highlights

Throughout his career, Michael J Konkel has worked with prominent companies in the pharmaceutical industry. Notable among these are H. Lundbeck A/S and Synaptic Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in mental health treatments.

Collaborations

Konkel has collaborated with several professionals in his field, including Jamie Talisman and John M Werzel. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Michael J Konkel's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the treatment of depression and anxiety through novel compounds highlight the importance of ongoing research and development in mental health therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…